StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)

Close on Nov 18, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Drugs Made In America Acquisition II

Drugs Made In America Acquisition II has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Drugs Made In America Acquisition II figures

See a number that looks wrong?